Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An RNA Sequencing Study in the Framingham Heart Study Third Generation Cohort Exam 2

NCT03225183 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT03225183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03225183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An RNA Sequencing Study in the Framingham Heart Study Third Generation Cohort Exam 2
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
July 14, 2017
Completion date
June 17, 2019
Enrollment
1,700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, hypertension